Additionally, Castello (72) discovered an association between metabolic tumor burden and sPD-L1 levels in NSCLC, while Kruger (65) revealed a link between sPD-L1 and sPD-1 with systemic inflammation in pancreatic cancer. Here, HOXD13 is linked to pancreatic neoplasm.